Zevra Therapeutics, Inc. (ZVRA) Gross profit 2018–2023
Zevra Therapeutics, Inc. (ZVRA) annual gross profit history from SEC filings — each fiscal year as reported.
$24.5MFY2023 · since FY2018: $0 → $24.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $24.5M | +146.7% |
| FY2022 | $9.9M | -62.6% |
| FY2021 | $26.6M | — |
| FY2019 | $2.8M | — |
| FY2018 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZVRA financial trends
ZVRA RevenueZVRA Net incomeZVRA Net marginZVRA Gross marginZVRA Operating incomeZVRA Operating marginZVRA Operating cash flowZVRA Free cash flowZVRA Capital expendituresZVRA Return on equityZVRA Stock buybacksZVRA Dividends paidZVRA Total assetsZVRA Total liabilitiesZVRA Shareholders’ equityZVRA overview →